Yilmaz Y - Search Results

1

Caspase-cleaved fragments of cytokeratin 18 in patients with chronic hepatitis B.

Eren F, Yilmaz Y, Kose S, Ozdemir FT, Yonal O, Kurt R, Ozdogan O, Avsar E. Eren F, et al. Among authors: yilmaz y. Clin Chim Acta. 2010 Dec 14;411(23-24):2029-32. doi: 10.1016/j.cca.2010.08.035. Epub 2010 Aug 31. Clin Chim Acta. 2010. PMID: 20807521

2

Liver disease as a risk factor for cognitive decline and dementia: an under-recognized issue.

Yilmaz Y, Ozdogan O. Yilmaz Y, et al. Hepatology. 2009 Feb;49(2):698; author reply 698. doi: 10.1002/hep.22752. Hepatology. 2009. PMID: 19177568 No abstract available.

3

Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C.

Yilmaz Y, Dolar E, Ulukaya E, Akgoz S, Keskin M, Kiyici M, Yerci O, Oral AY, Gul CB, Gurel S, Nak SG, Gulten M. Yilmaz Y, et al. Med Sci Monit. 2009 Apr;15(4):CR189-93. Med Sci Monit. 2009. PMID: 19333204

4

Dipeptidyl peptidase IV inhibitors: therapeutic potential in nonalcoholic fatty liver disease.

Yilmaz Y, Atug O, Yonal O, Duman D, Ozdogan O, Imeryuz N, Kalayci C. Yilmaz Y, et al. Med Sci Monit. 2009 Apr;15(4):HY1-5. Med Sci Monit. 2009. PMID: 19333209

5

Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity.

Keskin M, Dolar E, Dirican M, Kiyici M, Yilmaz Y, Gurel S, Nak SG, Erdinc S, Gulten M. Keskin M, et al. Among authors: yilmaz y. Intern Med J. 2009 Apr;39(4):243-8. doi: 10.1111/j.1445-5994.2009.01793.x. Intern Med J. 2009. PMID: 19402863

6

Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis.

Tiftikci A, Atug O, Yilmaz Y, Eren F, Ozdemir FT, Yapali S, Ozdogan O, Celikel CA, Imeryuz N, Tozun N. Tiftikci A, et al. Among authors: yilmaz y. Arch Med Res. 2009 May;40(4):294-8. doi: 10.1016/j.arcmed.2009.04.008. Arch Med Res. 2009. PMID: 19608019

7

Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis.

Yilmaz Y, Kedrah AE, Ozdogan O. Yilmaz Y, et al. World J Gastroenterol. 2009 Sep 21;15(35):4387-91. doi: 10.3748/wjg.15.4387. World J Gastroenterol. 2009. PMID: 19764089 Free PMC article. Review.

8

Systematic review: caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease.

Yilmaz Y. Yilmaz Y. Aliment Pharmacol Ther. 2009 Dec 1;30(11-12):1103-9. doi: 10.1111/j.1365-2036.2009.04148.x. Epub 2009 Sep 21. Aliment Pharmacol Ther. 2009. PMID: 19769633 Review.

9

Non-alcoholic fatty liver disease and microalbuminuria in non-diabetic patients: role of insulin resistance.

Yilmaz Y, Alahdab YO, Ozdogan O, Dolar E. Yilmaz Y, et al. Intern Med J. 2009 Oct;39(10):709-10. doi: 10.1111/j.1445-5994.2009.02029.x. Intern Med J. 2009. PMID: 19849765 No abstract available.

10

Metformin, hepatitis C, and insulin resistance: sufficient evidence?

Yilmaz Y, Yonal O, Imeryuz N. Yilmaz Y, et al. Hepatology. 2009 Dec;50(6):2054-5; author reply 2055. doi: 10.1002/hep.23359. Hepatology. 2009. PMID: 19937685 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

956 results

Search Page

Filters